Atherosclerosis
Volume 209, Issue 1 , Pages 74-80, March 2010

Vaccination against Foxp3+ regulatory T cells aggravates atherosclerosis

  • T. van Es

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
    • These authors contributed equally.
  • ,
  • G.H.M. van Puijvelde

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
    • These authors contributed equally.
    • Corresponding Author InformationCorresponding author at: LACDR, Div. of Biopharmaceutics, Gorlaeus Laboratories, Einsteinweg 55, PO Box 9502, 2300 RA Leiden, The Netherlands. Tel.: +31 71 5276051; fax: +31 71 5276032.
  • ,
  • A.C. Foks

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
  • ,
  • K.L.L. Habets

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
  • ,
  • I. Bot

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
  • ,
  • E. Gilboa

      Affiliations

    • Department of Surgery, Duke Center for Translational Research, Durham, NC, United States
  • ,
  • T.J.C. Van Berkel

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands
  • ,
  • J. Kuiper

      Affiliations

    • Division of Biopharmaceutics, Leiden University, Leiden, The Netherlands

Received 24 July 2009; received in revised form 20 August 2009; accepted 21 August 2009. published online 18 September 2009.

Abstract 

Objective

Regulatory T cells are crucial for immune homeostasis and an impaired regulatory T cell function results in many pathological conditions. Regulatory T cells have already been described to be protective in atherosclerosis. However the exact contribution of Foxp3-expressing natural regulatory T cells in atherosclerosis has not been elucidated yet.

Methods and results

In this study we vaccinated LDL receptor deficient mice with dendritic cells which are transfected with Foxp3 encoding mRNA and studied the effect on initial atherosclerosis. Vaccination against Foxp3 resulted in a reduction of Foxp3+ regulatory T cells in several organs and in an increase in initial atherosclerotic lesion formation. Furthermore we observed an increase in plaque cellularity and increased T cell proliferation in the Foxp3 vaccinated mice.

Conclusion

We further establish the protective role of Tregs in atherosclerosis. The results illustrate the important role for Foxp3-expressing regulatory T cells in atherosclerosis, thereby providing a potential opportunity for therapeutic intervention against this disease.

Keywords: Atherosclerosis, Inflammation, Vaccination, Regulatory T cells, Foxp3

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0021-9150(09)00703-5

doi:10.1016/j.atherosclerosis.2009.08.041

Atherosclerosis
Volume 209, Issue 1 , Pages 74-80, March 2010